[Influence of IMAO on glycemic equilibrium: potentiation of insulinic hypoglycemia by beta-phenyl-ethyl-hydrazine (Nardil)].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000378:metabolism*; D003863:Depression / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced*; D007328:Insulin; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use*
D001786:Blood Glucose; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D010624:Phenelzine
Influenza degli I.M.A.O. sull'equilibrio glicemico: potenziamento della ipoglicemia insulinica da parte della beta-fenil-etil-idrazina (nardil)